Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigationResearch in context

Summary: Background: How cardiovascular diseases (CVD) predispose to a higher risk of fragility fractures is not well understood. Both contribute to significant components of disease burden and health expenditure. Poor bone quality, central obesity, sarcopenia, falls, and low grip strength are inde...

Full description

Saved in:
Bibliographic Details
Main Authors: Karl Michaëlsson, Rui Zheng, John A. Baron, Tove Fall, Alicja Wolk, Lars Lind, Jonas Höijer, Carl Brunius, Eva Warensjö Lemming, Olga E. Titova, Bodil Svennblad, Susanna C. Larsson, Shuai Yuan, Håkan Melhus, Liisa Byberg, Hannah L. Brooke
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396425000246
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825206912166133760
author Karl Michaëlsson
Rui Zheng
John A. Baron
Tove Fall
Alicja Wolk
Lars Lind
Jonas Höijer
Carl Brunius
Eva Warensjö Lemming
Olga E. Titova
Bodil Svennblad
Susanna C. Larsson
Shuai Yuan
Håkan Melhus
Liisa Byberg
Hannah L. Brooke
author_facet Karl Michaëlsson
Rui Zheng
John A. Baron
Tove Fall
Alicja Wolk
Lars Lind
Jonas Höijer
Carl Brunius
Eva Warensjö Lemming
Olga E. Titova
Bodil Svennblad
Susanna C. Larsson
Shuai Yuan
Håkan Melhus
Liisa Byberg
Hannah L. Brooke
author_sort Karl Michaëlsson
collection DOAJ
description Summary: Background: How cardiovascular diseases (CVD) predispose to a higher risk of fragility fractures is not well understood. Both contribute to significant components of disease burden and health expenditure. Poor bone quality, central obesity, sarcopenia, falls, and low grip strength are independent risk factors for hip and other fragility fractures and also for CVD and early death. Methods: We used proteomics and a cohort design combined with Mendelian randomisation analysis to understand shared mechanisms for developing CVD and fragility fractures, two significant sources of disease burden and health expenditure. We primarily aimed to discover and replicate the association of 274 cardio-metabolic-related proteins with future rates of hip and any fracture in two separate population-based cohorts, with a total of 12,314 women and men. Findings: The average age at baseline was 68 years in the discovery cohort of women and 74 years in the mixed-sex replication cohort. During 100,619 person-years of follow-up, 2168 had any fracture, and 538 had a hip fracture. Our analysis resulted in 24 cardiometabolic proteins associated with fracture risk: 20 with hip fracture, 9 with any fracture, and 5 with both. The associations remained even if protein concentrations were measured from specimens taken during preclinical stages of cardio-metabolic diseases, and 19 associations remained after adjustment for bone mineral density. Twenty-two of the proteins were associated with total body fat mass or lean body mass. Mendelian randomisation (MR) analysis supported causality since genetically predicted levels of SOST (Sclerostin), CCDC80 (Coiled-coil domain-containing protein 80), NT-proBNP (N-terminal prohormone brain natriuretic peptide), and BNP (Brain natriuretic peptide) were associated with risk of hip fracture. MR analysis also revealed a possible negative impact on bone mineral density (BMD) by genetically predicted higher levels of SOST, CCDC80, and TIMP4 (Metalloproteinase inhibitor 4). The MR association with BMD was positive for PTX3 (Pentraxin-related protein) and SPP1 (Osteopontin). Genetically predicted higher concentrations of SOST and lower concentrations of SPP1 also conferred a higher risk of falls and lowered grip strength. The genetically determined concentration of nine proteins influenced fat mass, and one influenced lean body mass. Interpretation: These data reveal biological links between cardiovascular diseases and fragility fractures. The proteins should be further evaluated as shared targets for developing pharmacological interventions to prevent fractures and cardiovascular disease. Funding: The study was supported by funding from the Swedish Research Council (https://www.vr.se; grants No. 2015-03257, 2017-00644, 2017-06100, and 2019-01291 to Karl Michaëlsson) and funding from Olle Engkvist Byggmästares stiftelse (SOEB).
format Article
id doaj-art-eb333e4c94e14859a955208a3cc2d741
institution Kabale University
issn 2352-3964
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj-art-eb333e4c94e14859a955208a3cc2d7412025-02-07T04:47:47ZengElsevierEBioMedicine2352-39642025-03-01113105580Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigationResearch in contextKarl Michaëlsson0Rui Zheng1John A. Baron2Tove Fall3Alicja Wolk4Lars Lind5Jonas Höijer6Carl Brunius7Eva Warensjö Lemming8Olga E. Titova9Bodil Svennblad10Susanna C. Larsson11Shuai Yuan12Håkan Melhus13Liisa Byberg14Hannah L. Brooke15Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, SwedenClinical Epidemiology, Department of Medical Sciences, Uppsala University, Uppsala, SwedenMedical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USAMolecular Epidemiology, Department of Medical Sciences, Uppsala University, Uppsala, SwedenUnit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenClinical Epidemiology, Department of Medical Sciences, Uppsala University, Uppsala, SwedenMedical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, SwedenFood and Nutrition Science, Department of Life Sciences, Chalmers University of Technology, Gothenburg, SwedenMedical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, SwedenMedical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, SwedenMedical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, SwedenMedical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenUnit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenClinical Pharmacology, Department of Medical Sciences, Uppsala University, Uppsala, SwedenMedical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, SwedenMedical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Corresponding author.Summary: Background: How cardiovascular diseases (CVD) predispose to a higher risk of fragility fractures is not well understood. Both contribute to significant components of disease burden and health expenditure. Poor bone quality, central obesity, sarcopenia, falls, and low grip strength are independent risk factors for hip and other fragility fractures and also for CVD and early death. Methods: We used proteomics and a cohort design combined with Mendelian randomisation analysis to understand shared mechanisms for developing CVD and fragility fractures, two significant sources of disease burden and health expenditure. We primarily aimed to discover and replicate the association of 274 cardio-metabolic-related proteins with future rates of hip and any fracture in two separate population-based cohorts, with a total of 12,314 women and men. Findings: The average age at baseline was 68 years in the discovery cohort of women and 74 years in the mixed-sex replication cohort. During 100,619 person-years of follow-up, 2168 had any fracture, and 538 had a hip fracture. Our analysis resulted in 24 cardiometabolic proteins associated with fracture risk: 20 with hip fracture, 9 with any fracture, and 5 with both. The associations remained even if protein concentrations were measured from specimens taken during preclinical stages of cardio-metabolic diseases, and 19 associations remained after adjustment for bone mineral density. Twenty-two of the proteins were associated with total body fat mass or lean body mass. Mendelian randomisation (MR) analysis supported causality since genetically predicted levels of SOST (Sclerostin), CCDC80 (Coiled-coil domain-containing protein 80), NT-proBNP (N-terminal prohormone brain natriuretic peptide), and BNP (Brain natriuretic peptide) were associated with risk of hip fracture. MR analysis also revealed a possible negative impact on bone mineral density (BMD) by genetically predicted higher levels of SOST, CCDC80, and TIMP4 (Metalloproteinase inhibitor 4). The MR association with BMD was positive for PTX3 (Pentraxin-related protein) and SPP1 (Osteopontin). Genetically predicted higher concentrations of SOST and lower concentrations of SPP1 also conferred a higher risk of falls and lowered grip strength. The genetically determined concentration of nine proteins influenced fat mass, and one influenced lean body mass. Interpretation: These data reveal biological links between cardiovascular diseases and fragility fractures. The proteins should be further evaluated as shared targets for developing pharmacological interventions to prevent fractures and cardiovascular disease. Funding: The study was supported by funding from the Swedish Research Council (https://www.vr.se; grants No. 2015-03257, 2017-00644, 2017-06100, and 2019-01291 to Karl Michaëlsson) and funding from Olle Engkvist Byggmästares stiftelse (SOEB).http://www.sciencedirect.com/science/article/pii/S2352396425000246Cardiovascular diseasesFragility fracturesCohort studiesMendelian randomisationProteomics
spellingShingle Karl Michaëlsson
Rui Zheng
John A. Baron
Tove Fall
Alicja Wolk
Lars Lind
Jonas Höijer
Carl Brunius
Eva Warensjö Lemming
Olga E. Titova
Bodil Svennblad
Susanna C. Larsson
Shuai Yuan
Håkan Melhus
Liisa Byberg
Hannah L. Brooke
Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigationResearch in context
EBioMedicine
Cardiovascular diseases
Fragility fractures
Cohort studies
Mendelian randomisation
Proteomics
title Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigationResearch in context
title_full Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigationResearch in context
title_fullStr Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigationResearch in context
title_full_unstemmed Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigationResearch in context
title_short Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigationResearch in context
title_sort cardio metabolic related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures a cohort and mendelian randomisation investigationresearch in context
topic Cardiovascular diseases
Fragility fractures
Cohort studies
Mendelian randomisation
Proteomics
url http://www.sciencedirect.com/science/article/pii/S2352396425000246
work_keys_str_mv AT karlmichaelsson cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext
AT ruizheng cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext
AT johnabaron cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext
AT tovefall cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext
AT alicjawolk cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext
AT larslind cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext
AT jonashoijer cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext
AT carlbrunius cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext
AT evawarensjolemming cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext
AT olgaetitova cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext
AT bodilsvennblad cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext
AT susannaclarsson cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext
AT shuaiyuan cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext
AT hakanmelhus cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext
AT liisabyberg cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext
AT hannahlbrooke cardiometabolicrelatedplasmaproteinsrevealbiologicallinksbetweencardiovasculardiseasesandfragilityfracturesacohortandmendelianrandomisationinvestigationresearchincontext